scientific program • symposia - American Society for Reproductive ...

FERTILITY PRESERVATION
ROOM 330 E
Moderators: Lynn Westphal
Irene Su
O-157 4:15 PM
YOUNGER AGE OF EXPOSURE TO CHEMOTHERAPY LEADS
TO HIGHER RATES OF EARLY MENOPAUSE IN WOMEN WHO
CONTINUE TO MENSTRUATE AFTER CANCER TREATMENT.
J. M. Letourneau, E. E. Ebbel, M. P. Rosen. Obstetrics, Gynecology
and Reproductive Sciences, University of California, San Francisco,
San Francisco, CA.
O-158 4:30 PM
GONADOTROPIN-RELEASING HORMONE ANALOGUE
COTREATMENT DOES NOT PRESERVE OVARIAN FUNCTION
IN YOUNG WOMEN RECEIVING CYCLOPHOSPHAMIDE-
BASED CHEMOTHERAPY: A PROSPECTIVE, MULTICENTER,
RANDOMIZED TRIAL.
E. A. Elgindy 1 , D. O. El-Haieg 1 , O. M. Khorshid 2 , E. Ismail 3 , A. M. Abou-
Setta 4 , H. N. Sallam 5 . 1 Obstetrics and Gynecology, Zagazig University
School of Medicine, Zagazig, Sharkya, Egypt; 2 Medical Oncology,
National Cancer Institute, Cairo University School of Medicine,
Cairo, Giza, Egypt; 3 Clinical Oncology, Zagazig University School of
Medicine, Zagazig, Sharkya, Egypt; 4 eAlberta Research Centre for
Health Evidence, University of Alberta, Alberta, Canada; 5 Obstetrics
and Gynecology, Alexandria University School of Medicine,
Alexandria, Egypt.
O-159 4:45 PM
FERTILITY PRESERVATION TREATMENTS AND OUTCOMES IN
PATIENTS WITH HEMATOLOGIC DISORDERS.
S. Senapati 1 , C. B. Morse 1 , J. Kim 2 , J. Mersereau 2 , B. Efymow 1 , C.
Gracia 1 . 1 Obstetrics and Gynecology, University of Pennsylvania,
Philadelphia, PA; 2 Obstetrics and Gynecology, University of North
Carolina, Chapel Hill, Chapel Hill, NC.
O-160 5:00 PM
42 OOCYTE CRYOPRESERVATION (OC)/THAW CYCLES WITH
LIVEBIRTH OUTCOME IN HEALTHY WOMEN AFTER SLOW
COOLING (SC) AND VITRIFICATION (VIT) USING OOCYTES
RETRIEVED AT LESS THAN AGE 40. DOES METHOD MATTER?
N. Noyes, R. S. Weinerman, P. A. LaBella. NYU Fertility Center, New
York University School of Medicine, New York, NY.
O-161 5:15 PM
THE EFFICACY AND SAFETY OF FERTILITY PRESERVATION
USING OVARIAN STIMULATION AND OOCYTE OR EMBRYO
CRYOPRESERVATION IN FEMALE CANCER PATIENTS.
J. Y. Kim, B. E. Friedman, L. M. Westphal. Division of Reproductive
Endocrinoloogy & Infertility, Dept. of Ob/Gyn, Stanford University
School of Medicine, Stanford, CA.
O-162 5:30 PM
ACTIVATION OF DORMANT FOLLICLES FOLLOWED BY
PRODUCTION OF VIABLE EMBRYOS AND OFFSPRING VIA IN
VITRO MATURATION AND FERTILIZATION.
R. L. Krisher 1 , M. Paczkowski 1 , K. J. Strauss 1 , W. B. Schoolcraft 2 .
1 National Foundation for Fertility Research, Lone Tree, CO;
2 Colorado Center for Reproductive Medicine, Lone Tree, CO.
O-163 5:45 PM
ADDITION OF FIBRINOGEN TO THE 3-DIMENSIONAL (3D)
MATRIX PROMOTES IN VITRO DEVELOPMENT OF PRIMATE
PRIMARY, BUT NOT SECONDARY, FOLLICLES WITH ANTI-
MÜLLERIAN HORMONE (AMH) PRODUCTION.
J. Xu, M. S. Lawson, R. R. Yeoman, R. L. Stouffer, M. B. Zelinski. Division
of Reproductive Sciences, Oregon National Primate Research
Center, Oregon Health & Science University, Beaverton, OR.
ORAL ABSTRACTS
115
O-164 6:00 PM
IN-VITRO MATURATION OF OOCYTES FROM OVARIAN TISSUE
EXPANDS FERTILITY PRESERVATION OPTIONS.
L. Clark 1 , W. Vitek 2 , J. Witmyer 2 , R. Hackett 2 , S. A. Carson 2 , J. Robins 2 .
1 Department of Obstetrics and Gynecology, Women & Infants
Hospital of Rhode Island, Warren Alpert Medical School at Brown
University, Providence, RI; 2 Division of Reproductive Endocrinology
and Infertility, Women & Infants Hospital of Rhode Island, Warren
Alpert Medical School at Brown University, Providence, RI.
__________________________________________________________
FIBROIDS
ROOM 330 F
Moderators: Gregory Christman
O-165 4:15 PM
UTERINE FIBROIDS: FROM PREGNANCY TO NEONATAL
OUTCOMES.
R. Asaad1 , R. Najeemuddin1 , A. O. Hammoud2 , S. L. Hendrix1 , G.
McNeeley1 , M. P. Diamond1 . 1OB/GYN, Wayne State University,
Detroit, MI; 2REI, University of Utah, Salt Lake City, UT.
O-166 4:30 PM
RACIAL DIVERSITY IN UTERINE LEIOMYOMA.
N. Foyouzi1 , C.-N. Kao1 , M. Rosen1 , B. Sternfeld2 , M. I. Cedars1 .
1Obstetrics, Gynecology and Reproductive Sciences, University of
California San Francisco, UCSF Center for Reproductive Health, San
Francisco, CA; 2Kaiser Permanente Division of Research, Oakland
Kaiser Permanente, Oakland, CA.
O-167 4:45 PM
SONOGRAPHICALLY IDENTIFIED LARGE UTERINE FIBROIDS ARE
ASSOCIATED WITH SHORTENED CERVICAL LENGTH DURING
PREGNANCY.
V. I. Shavell, M. Thakur, A. Sawant, M. Singh, E. E. Puscheck, M. P.
Diamond. Division of Reproductive Endocrinology and Infertility,
Department of Obstetrics and Gynecology, Wayne State University
School of Medicine and the Detroit Medical Center, Detroit, MI.
O-168 5:00 PM
FOUR-AGENTS DECOCTION INHIBITS LEIOMYOMA CELL
GROWTH.
J.-Y. Liu 1 , C.-C. Wu 1 , Y.-J. Lee 1 , C.-C. Ou 1 , W.-C. Chu 1 , M.-C. Kao 2 .
1 Obstetrics and Gynecology, Tri-Service General Hospital, Taipei,
Taiwan; 2 Biological Science, China Medical University, Taichung,
Taiwan.
O-169 5:15 PM
LEIOMYOMA GROWTH MEDIATED BY DISRUPTIONS IN INJURY
RESPONSE AND ANGIOGENESIS.
W. H. Catherino 1,2 , M. Locastro 1 , M. Gilden 1 , J. Britten 1 , M. Malik 1 .
1 Obstetrics and Gynecology, Uniformed Services University of the
Health Sciences, Bethesda, MD; 2 Program in Reproductive and
Adult Endocrinology, National Institute of Child Health and Human
Development, Bethesda, MD.
O-170 5:30 PM
THE EXPRESSION AND FUNCTION OF miRNAs THAT DIRECTLY
TARGET TGF-ß FAMILY AND THEIR SIGNALING PATHWAY IN
LEIOMYOMA.
X. X. L. Luo, T.-D. C. Chuang, N. N. C. Chegini. Department of OB/
GYN, Univerisity of Florida, Gainesville, FL.
O-171 5:45 PM
FROM A LITTLE “SPARC” BURSTS A FLAME: DIFFERENTIAL
EXPRESSION AND REGULATION OF SECRETED PROTEIN
ACIDIC AND RICH IN CYSTEINE (SPARC) IN LEIOMYOMA AND
MYOMETRIUM.
E. E. Marsh, J. Wu, E. Cardozo, G. Ekpo, S. E. Bulun. Obstetrics and
Gynecology, Feinberg School of Medicine - Northwestern University,
Chicago, IL.